For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with ...

The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Two independent studies reveal that disease progression is delayed by combining two targeted therapies with the traditional ...

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

Lung cancer liver metastases are tumors that form in the liver from cancer cells that have broken away from the primary cancer. Metastasis may also be simply referred to as cancer spread. If you have ...

Dec. 13, 2024 — New research highlights the possibility of screening people with type 2 diabetes for liver damage at the same time as they undergo screening for eye ... Microbiome Changes in ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

When facing a cancer diagnosis, finding the most effective and innovative treatment options is crucial. Germany has emerged as a leading destination for advanced cancer treatments, offering ...

Liver cyst symptoms are often absent in the early stages but can lead to pain, vomiting, and shortness of breath as these fluid-filled sacs increase in size. Also known as hepatic cysts, they can ...